Stockreport

Biomarin Could Possibly Be The First To Obtain FDA Approval For Hemophilia Gene Therapy Treatment [Seeking Alpha]

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
PDF SummaryBiomarin had its BLA accepted by the FDA for its gene therapy valoctocogene roxaparvovec which is being used to treat patients with severe Hemophilia A.The entire [Read more]